Macrocyclic retroviral protease inhibitors

Details Macrocyclic retroviral protease inhibitors Macrocyclic retroviral protease inhibitors

1995-03-20

1998-11-03

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

540454, 540460, A61K 3133, C07D48700, C07D27300, C07D28500

Patent

active

058308881

ABSTRACT:
The present invention relates to N-heterocyclic-containing macrocyclic hydroxyethylamine protease inhibitor compounds, compositions and methods for inhibiting retroviral proteases.

REFERENCES:
patent: H725 (1990-01-01), Gordon
patent: 4599198 (1986-07-01), Hoover
Tet. Lett., 33:1725-1728 (1992).
Tet. Lett., 32:2453-6 (1991).
J. Med. Chem., 34:2692-2701 (1991).
12th APS, 816-7 (1991).
Tet. Lett., 32:7655-7658 (1991).
J. Med. Chem., 34:1276-1282 (1991).
12th APS, 749-51 (1991).
J. Chem. Soc. Chem. Commun., 666-7 (1990).
J. Med. Chem., 31:284-295 (1988).
Roberts et al, Science, 248, 358-361 (1990).
Erickson et al, Science, 249:527-533 (1990).
Pure Appl. Chem., 45, 13-30 (1976).
Creger, P.L., Org. Synth., VI, 517 (1988).

Affiliated with

Also associated with

Rating

Macrocyclic retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrocyclic retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic retroviral protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-689362